Sex differences in micro- and macro-vascular complications of diabetes mellitus
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Vascular complications are a leading cause of morbidity and mortality in both men and women with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus, however the prevalence, progression and pathophysiology of both microvascular (nephropathy, neuropathy and retinopathy) and macrovascular [coronary heart disease (CHD), myocardial infarction, peripheral arterial disease (PAD) and stroke] disease are different in the two sexes. In general, men appear to be at a higher risk for diabetic microvascular complications, while the consequences of macrovascular complications may be greater in women. Interestingly, in the absence of diabetes, women have a far lower risk of either micro- or macro-vascular disease compared with men for much of their lifespan. Thus, the presence of diabetes confers greater risk for vascular complications in women compared with men and some of the potential reasons, including contribution of sex hormones and sex-specific risk factors are discussed in this review. There is a growing body of evidence that sex hormones play an important role in the regulation of cardiovascular function. While estrogens are generally considered to be cardioprotective and androgens detrimental to cardiovascular health, recent findings challenge these assumptions and demonstrate diversity and complexity of sex hormone action on target tissues, especially in the setting of diabetes. While some progress has been made toward understanding the underlying mechanisms of sex differences in the pathophysiology of diabetic vascular complications, many questions and controversies remain. Future research leading to understanding of these mechanisms may contribute to personalized- and sex-specific treatment for diabetic micro- and macro-vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the case of diabetes, micro-vascular alterations secondary to hyperglycemia, which are more prevalent in women, 54”
From Defining risk factors associated with difficult peripheral venous Cannulation: A systematic review and meta-analysis (2020) · cites this paper as [54]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Research works printed but not linked: 2
- Brand, 1989, Diabetes, intermittent claudication, and risk of cardiovascular events, The Framingham Study. Diabetes, 38, 504
- Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study, A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med., 138, 1
Cited by
Items 201–221 of 221
Chase-Vilchez, A., Chan, I. H. Y., Peters, S. A. E., & Woodward, M. (2020) · Figshare · doi:10.6084/m9.figshare.13011864
Inglis, A. L., Ubungen, R., Farooq, S. A., Mata, P., Thiam, J., Saleh, S., Shibin, S., Al-Mohanna, F. A., & Collison, K. S. (2021) · Figshare · doi:10.6084/m9.figshare.14211348
Chase-Vilchez, A., Chan, I. H. Y., Peters, S. A. E., & Woodward, M. (2020) · Figshare · doi:10.6084/m9.figshare.13011840
Chase-Vilchez, A., Chan, I. H. Y., Peters, S. A. E., & Woodward, M. (2020) · Figshare · doi:10.6084/m9.figshare.13011849
Chase-Vilchez, A., Chan, I. H. Y., Peters, S. A. E., & Woodward, M. (2020) · Figshare · doi:10.6084/m9.figshare.13011846
Cesaroni, G., Mureddu, G. F., Agabiti, N., Mayer, F., Stafoggia, M., Forastiere, F., Latini, R., Masson, S., Davoli, M., & Boccanelli, A. (2021) · Figshare · doi:10.6084/m9.figshare.14131172
Chase-Vilchez, A., Chan, I. H. Y., Peters, S. A. E., & Woodward, M. (2020) · Figshare · doi:10.6084/m9.figshare.13011861
(n.d.) · RWTH Publications (RWTH Aachen)
Zulfiqar, M., Shah, S. R., Sajjad, A., Uddin, A., Talib, A., Dhedhi, H. A. A., Aamir, M. S., Yokolo, H., & Afridi, M. K. (2026) · Research Square · doi:10.21203/rs.3.rs-8880840/v1
O’Gorman, S. A., Keske, M. A., Parker, D. L., Kaur, G., Sacre, J. W., Terada, T., & Way, K. L. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00787.2025
Brishti, M. A., Mandal, M., Singh, U. P., Ishrat, T., & Leo, M. D. (2026) · Cells · doi:10.3390/cells15050455
“Among these, diabetic vasculopathy (DVD), marked by endothelial dysfunction, impaired vascular reactivity, and chronic low-grade inflammation, is a major driver of morbidity and mortality [3,4].”
Mustafa, M. S., Faisal, H., Imran, T., Salman, M., Rashid, A. J. M., Khan, F., & Aminpoor, H. (2026) · Research Square · doi:10.21203/rs.3.rs-9179604/v1
Différences de soins liées au sexe chez les personnes diabétiques de type 2 de la cohorte Constances
Paquet, S. (2023) · theses.fr (ABES) · doi:10.70675/ac7c0a65zf6d4z4138za1c8z2b3db605bfe1
Ding, Y., Wei, S., Shi, J., Zhang, Z., Yu, Y., Xiang, Y., Zhang, X., Song, D., Xiang, Y., Shen, Y., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113330
Sex and Alternative Splicing in Disease: a meta-analytic approach to identify interactionsPreprint
Keil, N., Morse, A. M., Callahan, C. M., CONCANNON, P. J., & McIntyre, L. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.29.728908
Zhang, J., Zhang, B., & He, C. (2026) · Turkish Journal of Physical Medicine and Rehabilitation · doi:10.5606/tftrd.2026.16227
Ayis, S. A., Özdede, M., Gnudi, L., Alobaid, T., Pavlou, P., Mangelis, A., Fountoulakis, N., Goubar, A., & Karalliedde, J. J. (2026) · Diabetic Medicine · doi:10.1111/dme.70469
Keser, N., Korkmaz, Y., Doğan, S., ŞEKER, M. M., Yavuz, S., Oğuz, M., Erdem, A., Yılmaz, İ., Oğuz, M., Torun, A., et al. (2026) · Clinics · doi:10.1016/j.clinsp.2026.101149
“22,23 The 2006 report of the US Surgeon General suggests that the simultaneous presence of smoking and another CVRF is estimated to quadruple cardiovascular risk.”
Long, Q., Kang, S., He, Q., Wang, H., Qi, X., Lin, S., Song, X., Guo, Q., & Liu, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1935387
“The sex-speci fi c pattern we identi fi ed is consistent with a growing body of evidence documenting sexual dimorphism in glycation biology and diabetic complications (32, 33).”
Zhao, C., Lu, H., Liu, F., & Qiao, Y. (2026) · Microorganisms · doi:10.3390/microorganisms14102361
Rajab, B. S., El‐Sebaey, A. M., Khan, A. A., Albukhari, T. A., Refaat, B., Sembawa, H., Bagadood, R. M., Albukhari, E. T., Nasreldin, N., & El‐Boshy, M. (2026) · Biology · doi:10.3390/biology15211988
Metadata
- Authors
- Maric-Bilkan, C.
- Affiliations
- Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, U.S.A.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2017-04-19
- Volume
- 131
- Issue
- 9
- Pages
- 833-846
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2605955340
- Cited by
- 217
- References
- 144
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 20 · 2023: 29 · 2022: 20 · 2021: 35 · 2020: 41 · 2019: 17 · 2018: 19 · 2017: 2
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- sex differences, diabetes mellitus, diabetic microvascular complications, diabetic macrovascular complications, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, coronary artery disease, myocardial infarction, peripheral arterial disease, stroke, sex hormones, estrogen, androgens, sex-specific risk factors, sex-specific treatment
- MeSH terms
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Female, Humans, Male, Risk Factors, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.